Cargando…

Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients

BACKGROUND: The aim of this study was to determine glutathione levels and antioxidant enzyme activities in the drug-naive first-episode patients with schizophrenia in comparison with healthy control subjects. METHODS: It was a case-controlled study carried on twenty-three patients (20 men and 3 wome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raffa, Monia, Atig, Fatma, Mhalla, Ahmed, Kerkeni, Abdelhamid, Mechri, Anwar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161936/ https://www.ncbi.nlm.nih.gov/pubmed/21810251 http://dx.doi.org/10.1186/1471-244X-11-124

Ejemplares similares

Impact of seminal trace element and glutathione levels on semen quality of Tunisian infertile men
por: Atig, Fatma, et al.
Publicado: (2012)

Altered Antioxidant Status and Increased Lipid Per-Oxidation in Seminal Plasma of Tunisian Infertile Men
por: Atig, Fatma, et al.
Publicado: (2011)

Oxidative stress and level of antioxidant enzymes in drug-naive schizophrenics
por: Reyazuddin, Mohammed, et al.
Publicado: (2014)

ACUTE SCHIZOPHRENIC EPISODES—ARE THEY SCHIZOPHRENIC?
por: Singh, Gurmeet, et al.
Publicado: (1981)

Cognitive effects of atypical antipsychotic drugs in first-episode drug-naïve schizophrenic patients
por: Wang, Juan, et al.
Publicado: (2013)

Antioxidant enzymes activities in obese Tunisian children
por: Sfar, Sonia, et al.
Publicado: (2013)

Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients
por: Hashimoto, Kenji, et al.
Publicado: (2005)

CSF AMINES AND THEIR METABOLITES IN FIRST EPISODE DRUG NAIVE SCHIZOPHRENIC PATIENTS AND THEIR CORRELATIONS WITH DIMENSIONS OF SCHIZOPHRENIA
por: Anand, I., et al.
Publicado: (2002)

Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use
por: Mhalla, Ahmed, et al.
Publicado: (2017)

Functionally aberrant electrophysiological cortical connectivities in first episode medication-naive schizophrenics from three psychiatry centers
por: Lehmann, Dietrich, et al.
Publicado: (2014)

Prevalence of Working Memory Impairment in Drug Naive Schizophrenic Patients in a Tertiary Care Hospital
por: Goit, Bharat Kumar, et al.
Publicado: (2019)

Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders
por: Jäger, Markus, et al.
Publicado: (2006)

Prospective Memory Impairments in Schizophrenic Patients
por: Bigdeli, Imanollah, et al.
Publicado: (2014)

Substance abuse in first-episode schizophrenic patients: a retrospective study
por: Mauri, MC, et al.
Publicado: (2006)

Depressive Symptoms during an Acute Schizophrenic Episode: Frequency and Clinical Correlates
por: Rajkumar, Ravi Philip
Publicado: (2015)

Haplotypes of TNFα/β Genes Associated with Sex-Specific Paranoid Schizophrenic Risk in Tunisian Population
por: Inoubli, Oumaima, et al.
Publicado: (2018)

Role of Antioxidant Enzymes and Glutathione S-Transferase in Bromoxynil Herbicide Stress Tolerance in Wheat Plants
por: Gaafar, Reda M., et al.
Publicado: (2022)

Classification of Depressive and Schizophrenic Episodes Using Night-Time Motor Activity Signal
por: Rodríguez-Ruiz, Julieta G., et al.
Publicado: (2022)

Large-scale networks underlie cognitive insight differs between untreated adolescents ongoing their first schizophrenic episode and their reference non-schizophrenic mates
por: Ji, Ruofei, et al.
Publicado: (2022)

Impaired Binocular Depth Perception in First-Episode Drug-Naive Patients With Schizophrenia
por: Wang, Zhengchun, et al.
Publicado: (2018)

Severe Burns and Amputation of Both Arms in the First Psychotic Episode of a Schizophrenic Patient
por: Cruzado, Lizardo, et al.
Publicado: (2015)

Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study
por: Liu, Haixia, et al.
Publicado: (2022)

Omega Class Glutathione S-Transferase: Antioxidant Enzyme in Pathogenesis of Neurodegenerative Diseases
por: Kim, Youngjo, et al.
Publicado: (2017)

Decreased Intrinsic Functional Connectivity in First-Episode, Drug-Naive Adolescents With Generalized Anxiety Disorder
por: Yang, Fan, et al.
Publicado: (2019)

The Prognostic Role of Glutathione and Its Related Antioxidant Enzymes in the Recurrence of Hepatocellular Carcinoma
por: Hsiao, Yung-Fang, et al.
Publicado: (2021)

Decreased Functional Connectivity of Insular Cortex in Drug Naïve First Episode Schizophrenia: In Relation to Symptom Severity
por: Pang, Lijuan, et al.
Publicado: (2017)

A Preliminary Study on the Potential Protective Role of the Antioxidative Stress Markers of Cognitive Impairment: Glutathione and Glutathione Reductase
por: Park, Sang-a, et al.
Publicado: (2023)

Impaired interactions among white‐matter functional networks in antipsychotic‐naive first‐episode schizophrenia
por: Fan, Yun‐Shuang, et al.
Publicado: (2019)

Pratique de l’électroconvulsivothérapie dans un hôpital universitaire Tunisien: The practice of electroconvulsivotherapy at a University Hospital in Tunisia
por: Mechri, Anwar, et al.
Publicado: (2018)

A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme
por: Magri, Chiara, et al.
Publicado: (2018)

Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome
por: Akyol, Esra Soydaş, et al.
Publicado: (2015)

Relationships between abnormal neural activities and cognitive impairments in patients with drug-naive first-episode schizophrenia
por: Yan, Wei, et al.
Publicado: (2020)

Optimizing and Individualizing the Pharmacological Treatment of First-Episode Schizophrenic Patients: Study Protocol for a Multicenter Clinical Trial
por: Xiao, Jingmei, et al.
Publicado: (2021)

Psychopathology in children of schizophrenics
por: Shah, Sharita, et al.
Publicado: (2003)

Who ‘Speaks’ to the Schizophrenic?
por: Ramanathan, A.
Publicado: (1986)

PENUFLURIDOL IN THE TREATMENT OF SCHIZOPHRENICS
por: Sharma, S. D.
Publicado: (1988)

Schizophrenic: forever young?
por: Baldi, Benedetta Frida, et al.
Publicado: (2010)

blind or schizophrenic but not both
por: Fatima Zahra, C., et al.
Publicado: (2022)

Schizophrenic or blind but not both
por: Chamsi, F.Z., et al.
Publicado: (2022)

Evaluation of serum amino acids and non-enzymatic antioxidants in drug-naïve first-episode major depressive disorder
por: Islam, Md. Rabiul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c5jdbog7jsakq9n22m59ledbio